Peritoneal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2007-04-24
Clinical Trial Update: Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers [Phase 2]
A Phase 2 trial evaluating weekly carboplatin and docetaxel in platinum-sensitive relapsed ovarian, fallopian tube, or primary peritoneal ca…
CLINICAL_TRIALS trial_result · 2007-01-26
Clinical Trial Update: A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. [Phase 3]
A Phase 3 randomized trial for platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed.
CLINICAL_TRIALS trial_result · 2006-11-08
Clinical Trial Update: Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients [Phase 2]
Phase IIa randomized, multicenter, open-label study to identify the better intraperitoneal dose of Removab (catumaxomab) in platinum-refract…
CLINICAL_TRIALS trial_result · 2006-11-07
Clinical Trial Update: Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer [Phase 2]
Pfizer-sponsored Phase 2 trial of an oral VEGFR-2 tyrosine kinase inhibitor for small-volume ovarian, peritoneal, and fallopian tube cancers…
CLINICAL_TRIALS trial_result · 2006-09-15
Clinical Trial Update: Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Gemzar (gemcitabine) and Alimta (pemetrexed) in patients with recurrent platinum-sensit…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2006-09-11
Clinical Trial Update: Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia [Phase 2]
Phase 2 trial of complete cytoreductive surgery with intraperitoneal chemohyperthermia for cancers involving the peritoneum was terminated; …